Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Clinical trial NCT00425321 · COMPLETED
Trial details
- NCT number
- NCT00425321
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2008-01-01
- Enrollment
- 259
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.